Article
ABC transporters and the accumulation of imatinib and its active metabolite CGP74588 in rat C6 glioma cells.
Pharmacological research - 1 Mar 2008
Declèves Xavier, Bihorel Sébastien, Debray Marcel, Yousif Salah, Camenisch Gian, Scherrmann Jean-Michel
Abstract excerpt
Imatinib (Glivec, Gleevec, STI571) is a small tyrosine kinase inhibitor that is currently in phase II clinical trials in patients with recurrent glioblastoma. Its therapeutic benefit is minimal, although it is greater in some patients when combined with hydroxyurea. Imatinib is transported by human and rodent ATP-binding cassette (ABC) transporters like P-glycoprotein (Pgp) and the breast cancer resistance...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
